Astrazeneca Pharma India Ltd vs Blue Jet Healthcare Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 05, 2026

Key Highlights

The Latest Trading Price of Astrazeneca Pharma India Ltd is ₹ 8233 as of 05 May 15:30 . The P/E Ratio of Astrazeneca Pharma India Ltd is 0 as of March 2021 .The P/E Ratio of Blue Jet Healthcare Ltd is 0 as of March 2021 . The Market Cap of Astrazeneca Pharma India Ltd is ₹ 0 crore as of March 2021 .The Market Cap of Blue Jet Healthcare Ltd is ₹ 0 crore as of March 2021 . The revenue of Astrazeneca Pharma India Ltd for the Dec '25 is ₹ 618.18 crore as compare to the Sep '25 revenue of ₹ 565.26 crore. This represent the growth of 9.36% The revenue of Blue Jet Healthcare Ltd for the Dec '25 is ₹ 205.62 crore as compare to the Sep '25 revenue of ₹ 189.75 crore. This represent the growth of 8.36% The ebitda of Astrazeneca Pharma India Ltd for the Dec '25 is ₹ 51.44 crore as compare to the Sep '25 ebitda of ₹ 76.06 crore. This represent the decline of -32.37% The ebitda of Blue Jet Healthcare Ltd for the Dec '25 is ₹ 60.1 crore as compare to the Sep '25 ebitda of ₹ 79.22 crore. This represent the decline of -24.14% The net profit of Astrazeneca Pharma India Ltd changed from ₹ -11.79 crore to ₹ 32.59 crore over 7 quarters. This represents a CAGR of NaN% The net profit of Blue Jet Healthcare Ltd changed from ₹ 37.78 crore to ₹ 40.17 crore over 7 quarters. This represents a CAGR of 3.57% The Dividend Payout of Astrazeneca Pharma India Ltd changed from 5.36 % on March 2021 to 69.12 % on March 2025 . This represents a CAGR of 66.76% over 5 yearsThe Dividend Payout of Blue Jet Healthcare Ltd changed from 10.59 % on March 2024 to 6.82 % on March 2025 . This represents a CAGR of -19.75% over 2 years .

About Astrazeneca Pharma India Ltd

AstraZeneca Pharma India Limited (APIL) was incorporated on July 11, 1979.
The Company is engaged in the business of manufacture, distribution and marketing of pharmaceutical products and co-ordinates clinical trial services with an overseas group company.
The major therapy areas where the company operates are Onocology, Alimentary & Metabolism, Cardio Vascular, Renal, Diabetes, Respiratory and Oncology. AstraZeneca Pharma India, formerly known as Astra-IDL (AIL), was an erstwhile joint venture of Astra Zeneca, UK and Hinduja controlled IDL. Astra Pharmaceuticals AB, Sweden acquired all of the 1287500 equity shares in the Company of IDL, representing 25.75% of the Company's issued and paid up equity share capital.
Consequently, the Company became a subsidiary of Astra, which is a direct wholly owned subsidiary of Astra AB, Sweden (now known as AstraZeneca Pharmaceuticals AB Sweden) and an indirect wholly owned subsidiary of AstraZeneca Plc, the Group parent Company.

About Blue Jet Healthcare Ltd

Blue Jet Healthcare Limited was originally incorporated as Jet Chemicals Private Limited,' at Mumbai, dated December 7, 1968.
The Company name was changed to Blue Jet Healthcare Private Limited', and a fresh Certificate of Incorporation dated December 30, 2020, was issued by the Registrar of Companies, Mumbai.
Subsequently, the status got converted into a Limited Company and its name was changed to Blue Jet Healthcare Limited' on May 18, 2022. The Company is a global, science-led, pharmaceutical company evolved as strategic partner for Collaboration, Development & Manufacturing of Advance Pharmaceutical Intermediates and API. It operate into 3 product categories, contrast media intermediates, high- intensity sweeteners, and pharma intermediates and active pharmaceutical ingredients (APIs).

FAQs for the comparison of Astrazeneca Pharma India Ltd and Blue Jet Healthcare Ltd

Which company has a larger market capitalization, Astrazeneca Pharma India Ltd or Blue Jet Healthcare Ltd?

Market cap of Astrazeneca Pharma India Ltd is 20,583 Cr while Market cap of Blue Jet Healthcare Ltd is 8,511 Cr

What are the key factors driving the stock performance of Astrazeneca Pharma India Ltd and Blue Jet Healthcare Ltd?

The stock performance of Astrazeneca Pharma India Ltd and Blue Jet Healthcare Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Astrazeneca Pharma India Ltd and Blue Jet Healthcare Ltd?

As of May 5, 2026, the Astrazeneca Pharma India Ltd stock price is INR ₹8233.5. On the other hand, Blue Jet Healthcare Ltd stock price is INR ₹490.7.

How do dividend payouts of Astrazeneca Pharma India Ltd and Blue Jet Healthcare Ltd compare?

To compare the dividend payouts of Astrazeneca Pharma India Ltd and Blue Jet Healthcare Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.